Selecting embryos that are most viable during in vitro fertilization (IVF) process is a delicate task that requires attention to detail and a keen eye for noticing changes. While still a task that requires expertise from a professional, a camera hooked up to a computer that performs video analysis can help clinicians pick embryos with a greater level of accuracy.
The Eeva System from Auxogyn just received FDA clearance for use by reproductive specialists to be used as a prognostic, non-invasive test of embryonic development. It’s used in addition to traditional morphology and provides quantitative data on the progress of the embryos. Take a look at the video below that shows the video output of how the system identifies cell development.
From the announcement:
Clearance of the Eeva Test was based on a multi-center, prospective clinical trial that clinically validated the test and found it to be informative in identifying embryos with the highest development potential, when used adjunctively after morphology. [Conaghan et al, 2013]
Results of a study, where a panel of five embryologists adjunctively used the Eeva Test, showed that the odds of an embryo reaching the critical blastocyst stage at day 5/6 is 2.57 times higher among embryos predicted to become a blastocyst versus those predicted to not reach blastocyst stage2. Using the Eeva Test adjunctively to morphology, the odds ratio rose 53 percent over traditional, morphological grading.
Product page: The Eeva Test from Auxogyn…
Press release: Auxogyn Receives FDA Clearance for Its Eeva™ System…